Increased percentage and the absolute number of Lin–/lowHLA-DR–CD11b+CD33+ MDSCs compared with healthy controls. This increase is closely correlated with clinical cancer stage and tumor metastasis but not primary tumor size. The gene discussed is CD33; the disease is neoplasm.